Antiviral Treatment Alters the Frequency of Activating and Inhibitory Receptor-Expressing Natural Killer Cells in Chronic Hepatitis B Virus Infected Patients
Figure 6
Antiviral treatments results in decrease of NKG2A and KIR2DL3 expression in patients with chronic HBV infection treated with tenofovir or adefovir. The frequency of NKG2A and KIR2DL3 expressing NK cells at baseline (0w), 12 w, and at 24 w of therapy. Data are shown in box-and-whisker plots (a)–(d). (TDF-group (a) (b)): changes in the frequency of inhibitory receptor+ NK cells; (ADV-group (c) (d)): changes in the frequency of inhibitory receptor+ NK cells.
